cp wire

CP Wire Articles

  • RSV causes 30 million infections and 200,000 deaths worldwide in children under 5 alone
  • The company's lead candidate, RV521, is currently in Ph II trials


... read more

Wed, 08/1/18 - 10:35 am
admin

Northern Biologics Inc. announced on 8/1/18 the appointment of Enda Moran, Ph.D., MBA, as vice president and head of Chemistry Manufacturing and Controls (CMC), and Frédéric Sweeney, Ph.D., as... read more

Wed, 08/1/18 - 10:12 am
admin
  • Currently available Enbrel biosimilars in China were not compared to the originator
  • Current biosimilars only available in lyophilized powder
  • SCB-808 will be available in pre... read more
Wed, 08/1/18 - 09:43 am
admin
  • Larazotide has received Fast Track designation from the FDA for celiac disease.
  • Innovate is preparing to enter Ph III registration clinical trials for celiac disease later in 2018... read more
Tue, 07/31/18 - 10:02 am
admin
  • Trazimera is Pfizer's first therapeutic oncology biosimilar to receive a positive CHMP opinion from the EMA.
  • Herceptin brought in $2.5 billion in the US alone in 2016

... read more

Tue, 07/31/18 - 09:44 am
admin
  • Approval makes Opdivo the only PD-1 with EC approval in adjucant setting
  • The indication is for both BRAF mutant and wild-type melanoma
  • Approval based on superior results vs... read more
Tue, 07/31/18 - 09:29 am
admin

Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at... read more

Tue, 07/31/18 - 09:17 am
admin


ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-... read more

Mon, 07/30/18 - 09:45 am
admin
  • HitGen also recently announced collaboration with Sanofi
  • The company's DNA Encoded Libraries contain more than 200 billion drug like compounds


HitGen Ltd. Announced... read more

Mon, 07/30/18 - 09:28 am
admin


 BeiGene, Ltd. (NASDAQ:BGNE) announced on 7/27/18 a Hong Kong initial public offering and a global offering (the “Offering”) of 65,600,000 of its ordinary shares and the proposed listing of... read more

Fri, 07/27/18 - 10:37 am
admin
  • European Medicines Agency reviewed patisiran under the accelerated assessment procedure
  • Patisiran is currently under priority review as a Breakthrough Therapy with the US FDA
  • ... read more
Fri, 07/27/18 - 10:01 am
admin



Merck (NYSE:MRK) announced on 7/26/18 that Keytruda, Merck’s anti-PD-1 therapy, has been approved by the China National Drug Administration (CNDA) for the treatment of adult patients with... read more

Thu, 07/26/18 - 09:47 am
admin
  • Sandoz's ANDA cannot be approved until after all patents expire in 2033
  • Omeros previously settled lawsuits against Par and Lupin


Omeros Corporation (Nasdaq: OMER)... read more

Thu, 07/26/18 - 09:12 am
admin
  • Tislelizumab is a monoclonal antibody PD-1 checkpoint inhibitor
  • BeiGene and Celgene have a global collaboration agreement for the development of  tislelizumab outside of Asia (except... read more
Wed, 07/25/18 - 09:49 am
admin
  • Finch has 34 US and Foreign Patents in Its portfolio
  • The Company has 60 patent applications pending

Finch Therapeutics Group... read more

Wed, 07/25/18 - 08:59 am
admin
  • Alunbrig demonstrated statistically superior progression-free survival vs crizotinib in patients with ALK+ NSCLC
  • Alunbrig previously received accelerated approval from the FDA for... read more
Wed, 07/25/18 - 08:49 am
admin
  • GSK ‘794 is an engineered T-cell therapy using patient's own cells
  • Ptoential payments to Adaptimmune could be as much as $500 million
  • Adaptimmune as three additional TCR... read more
Tue, 07/24/18 - 10:17 am
admin
  • At Week 96, 73.1 percent of the treatment group achieved viral suppression
  • Previously reported - at week 48 DOR met its primary efficacy endpoint of non-inferiority compared to DRV+r... read more
Tue, 07/24/18 - 09:55 am
admin
  • States with highest use of Truvada for PrEP had significant declines in HIV diagnoses
  • States with the lowest use saw increases in HIV diagnoses
  • Truvada was approved for HIV... read more
Tue, 07/24/18 - 09:43 am
admin

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.